The participation of myofibroblasts in the capsular formation of human conventional and chromophobe renal cell carcinomas

Histology and Histopathology

Volumn 20, Issue 1, 2005, Pages 67-73

  Shimasaki, N ^a   Kuroda, Naoto ^a   Guo, L ^a   Jin, Y ^a   Miyazaki, E ^a   Hayashi, Y ^a   Toi, M ^a   Hiroi, M ^a   Enzan, H ^a   Shuin, T ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Capsule; Human renal cell carcinomas; Myofibroblast

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; KIDNEY TUBULE EPITHELIUM; MALE; MYOFIBROBLAST;

CARCINOMA, RENAL CELL; COLLAGEN; FIBROBLASTS; HUMANS; MICROSCOPY, IMMUNOELECTRON;

EID: 19944381562     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cheng S. and Lovett D.H. (2003). Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transdifferentiation. Am. J. Pathol. 162, 1937-1949.
2. Diamond J.R., van Goor H., Ding G. and Engelmyer E. (1995). Myofibroblasts in experimental hydronephrosis. Am. J. Pathol. 146, 121-129.
3. Eddy A.A., Giachelli C.M., McCulloch L. and Liu E. (1995). Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int. 47, 1546-1557.
4. Eyden B. (2001). The myofibroblast: An assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct. Pathol. 25, 39-50.
5. Fan J.M., Ng Y.Y., Hill P.A., Nikolic-Paterson J., Mu W., Atkins R.C. and Lan H.Y. (1999). Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 56, 1455-1467.
6. Kovacs G., Akhtar M., Beckwith J.B., Bugert P., Cooper C.S., Delahunt B., Eble J.N., Fleming S., Ljungberg B., Medeiros L.J., Moch H., Reuter V.E., Ritz E., Roos G., Schimidt D., Srigley J.R., Störkel S., van den Berg E. and Zbar B. (1997). The Heidelberg classification of renal cell tumours. J. Pathol. 183, 131-133.
7. Kuroda N., Toi M., Miyazaki E., Hayashi Y., Nakayama H., Hiroi M. and Enzan H. (2002). Participation of α-smooth muscle actin-positive cells in renomedullary interstitial cell tumors. Oncol. Rep. 9, 745-750.
8. Kuroda N., Toi M., Hiroi M. and Enzan H. (2003a). Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. Histol. Histopathol. 18, 171-186.
9. Kuroda N., Toi M., Hiroi M., Shuin T. and Enzan H. (2003b). Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol. Histopathol. 18, 935-942.
10. Kuroda N., Toi M., Nakayama H., Miyazaki E., Yamamoto M., Hayashi Y., Hiroi M. and Enzan H. (2004). The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions. Histol. Histopathol. 19, 59-67.
11. Lagace R., Grimaud J.A., Schürch W. and Seemayer T.A. (1985). Myofibroblastic stromal reaction on carcinoma of the breast: variations of collagenous matrix and structural glycoproteins. Virchows Arch. Pathol. Anat. 408, 49-59.
12. Mizuno S., Kurosawa T., Matsumoto K., Mizumo-Horikawa Y., Okamoto M. and Nakamura T. (1998). Hopatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101, 1827-1834.
13. Muchaneta-Kubara E.C. and Nahas A.M.E. (1997). Myofibroblast phenotype expression in experimental renal scarring. Nephrol. Dial. Transplant. 12, 904-915.
14. Nakatsuji S., Yamate J. and Sakuma S. (1998). Relationship between vimentin expressing renal tubules and interstitial fibrosis in chronic progressive nephropathy in aged rats. Virchows Arch. 433, 359-367.
15. Nakayama H., Naruse K., Miyazaki E., Hiroi M., Kiyoku H., Kuroda N. and Enzan H. (1999). The specific distribution of dendritic interstitial cells at the tumor border of major salivary gland pleomorphic adenomas. Mod. Pathol. 12, 445-449.
16. Nakayama H., Enzan H., Miyazaki E., Moriki T., Kiyoku H., Toi M., Kuroda N. and Hiroi M. (2002). High molecular weight caldesmon positive stromal cells in the capsule of thyroid follicular tumours and tumour-like lesions. J. Clin. Pathol. 55, 917-920.
17. Ooi L.P.J., Crawford D.H.G., Gotley D.C., Clouston A.D., Strong R.W., Gobe G.C., Halliday J.W., Bridle K.R. and Ramm G.A. (1997). Evidence that "myofibroblast-like" cells are a cellular source of capsular collagen in hepatocellular carcinoma. J. Hepatol. 26, 798-807.
18. Ramm G.A., Nair V.G., Bridle K.R., Shepherd R.W. and Cranford D.H. (1998). Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am. J. Pathol. 153, 527-535.
19. Schürch W., Seemayer T.A. and Gabbiani G. (1998). The myofibroblast. A quarter century after its discovery. Am. J. Surg. Pathol. 22, 141-147.
20. Soma L., LiVolsi V.A. and Baloch Z.W. (2001). Dendritic interstitial and myofibroblastic cells at the tumor border of salivary gland tumors. Arch. Pathol. Lab. Med. 125, 232-236.
21. Störkel S., Eble J.N., Adlakha K., Amin M., Blute M.L., Bostwick D.G., Darson M., Delahunt B. and Iszkowski K. (1997). Classification of renal cell carcinoma: Workgroup No.1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80, 987-989.
22. Yang J. and Liu Y. (2001). Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159, 1465-1475.
23. Yang J. and Liu Y. (2002). Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13, 96-107.
24. Zeisberg M., Strutz F. and Muller G.A. (2001). Renal fibrosis: an update. Curr. Opin. Nephrol. Hypertens. 10, 315-320.